KIEU DANG: Open Payments
NPI 1437167327 · RENTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,976 in 186 payments from 20 companies in 2025. Trend: 2023 $3,732 · 2024 $3,491 · 2025 $3,976
Food & beverage: $3,876Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $669 |
| ABBVIE INC. | 23 | $451 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $348 |
| Regeneron Healthcare Solutions, Inc. | 9 | $320 |
| UCB, Inc. | 12 | $305 |
| PFIZER INC. | 11 | $290 |
| Novartis Pharmaceuticals Corporation | 18 | $270 |
| Galderma Laboratories, L.P. | 12 | $243 |
| GENZYME CORPORATION | 10 | $235 |
| Arcutis Biotherapeutics, Inc. | 16 | $227 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, COSENTYX, Zoryve, NEMLUVIO, LIBTAYO.
Industry payments across WA — which companies pay providers there.
